Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Inoviq Ltd ( (AU:IIQ) ) has issued an update.
INOVIQ Limited has released an investor briefing providing updates on its key programs, EXO-OC and CAR-exosomes. This announcement highlights the company’s ongoing efforts to enhance its position in the biotechnology sector by advancing its diagnostic and therapeutic solutions, which could have significant implications for stakeholders and the industry at large.
More about Inoviq Ltd
INOVIQ Limited operates in the biotechnology industry, focusing on the development of innovative diagnostic and therapeutic solutions. The company is engaged in key programs such as EXO-OC and CAR-exosomes, which are aimed at advancing medical technologies.
Average Trading Volume: 253,373
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$41.86M
For detailed information about IIQ stock, go to TipRanks’ Stock Analysis page.

